Achieve Life Sciences ACHV
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 2.67 | 101.99 | -0.37 | -12,894 | -13 | |
| 2024Q4 | 3.52 | 100.22 | -0.36 | -12,190 | -12 | |
| 2024Q3 | 4.74 | 102.63 | -0.38 | -12,466 | -13 | |
| 2024Q2 | 4.70 | 110.11 | -0.24 | -8,431 | -8 | |
| 2024Q1 | 4.55 | 105.30 | -0.26 | -5,982 | -6 | |
| 2023Q4 | 4.12 | 93.54 | -0.24 | -4,386 | -5 | |
| 2023Q3 | 4.30 | 103.87 | -0.33 | -6,572 | -7 | |
| 2023Q2 | 5.19 | 102.48 | -0.43 | -7,714 | -8 | |
| 2023Q1 | 6.80 | 101.89 | -0.50 | -8,578 | -9 | |
| 2022Q4 | 2.45 | 101.66 | -0.76 | -10,862 | -11 | |
| 2022Q3 | 3.30 | 100.34 | -1.35 | -12,639 | -13 | |
| 2022Q2 | 4.88 | 100.09 | -1.09 | -10,073 | -10 | |
| 2022Q1 | 7.57 | 100.14 | -0.80 | -7,226 | -8 | |
| 2021Q4 | 7.78 | 99.50 | -0.69 | -7,115 | -7 | |
| 2021Q3 | 8.50 | 100.03 | -0.54 | -6,693 | -7 | |
| 2021Q2 | 8.98 | 99.92 | -1.55 | -11,302 | -11 | |
| 2021Q1 | 11.58 | 99.81 | -1.30 | -7,984 | -8 | |
| 2020Q4 | 8.10 | 99.94 | -0.87 | -4,721 | -5 | |
| 2020Q3 | 8.37 | 99.73 | -0.76 | -3,754 | -4 | |
| 2020Q2 | 0.40 | 99.86 | -1.64 | -2,918 | -3 |